Promazine

• CAT Number: I035046
• CAS Number: 58-40-2
• Molecular Formula: C17H20N2S
• Molecular Weight: 284.42
• Purity: 98%
• Synonyms: Promazine; Sinophenin; Tomil; NSC 31447; Esparin; Sparine
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: 10H-Phenothiazine-10-propanamine, N,N-dimethyl- (9CI)
• InChI: InChI=1S/C17H20N2S/c1-18(2)12-7-13-19-14-8-3-5-10-16(14)20-17-11-6-4-9-15(17)19/h3-6,8-11H,7,12-13H2,1-2H3
• InChIKey: ZGUGWUXLJSTTMA-UHFFFAOYSA-N
• SMILES: CN(C)CCCN1C2=C(C=CC=C2)SC3=CC=CC=C13

Promazine (Cat.No:I035046) is a phenothiazine analogue of imipramine with actions similar to chlorpromazine but with less antipsychotic activity. It is primarily used in short-term treatment of disturbed behavior and as an antiemetic. It has predominantly anticholinergic side effects.

Reference

1: La Rocca R, Ferrari-Toninelli G, Patanè S. Widened QRS interval and left ventricular systolic depression after propafenone and promazine exposure. Int J Cardiol. 2014 Nov 15;177(1):57-60. doi: 10.1016/j.ijcard.2014.09.095. Epub 2014 Oct 11. PubMed PMID: 25499340.
2: Lasić D, Cvitanović MZ, Uglešić B, Višić V, Hlevnjak I. Exanthema medicamentosum as a side effect of promazine. Psychiatr Danub. 2011 Jun;23(2):194-7. PubMed PMID: 21685860.
3: Purohit AK, Balish MD, Leichty JJ, Roe A, Ward LM, Mitchell MO, Hsia SC. Antiviral activity and synthesis of quaternized promazine derivatives against HSV-1. Bioorg Med Chem Lett. 2012 Aug 15;22(16):5308-12. doi: 10.1016/j.bmcl.2012.06.031. Epub 2012 Jun 19. PubMed PMID: 22789428.
4: Dewey EA, Maylin GA, Ebel JG, Henion JD. The metabolism of promazine and acetylpromazine in the horse. Drug Metab Dispos. 1981 Jan-Feb;9(1):30-6. PubMed PMID: 6111428.
5: Syrek M, Wójcikowski J, Daniel W. Effect of carbamazepine on the pharmacokinetics of promazine. Pol J Pharmacol. 1996 Nov-Dec;48(6):601-8. PubMed PMID: 9112700.
6: Daniel W, Syrek M, Janczar L, Boksa J. The pharmacokinetics of promazine and its metabolites after acute and chronic administration to rats–a comparison with the pharmacokinetics of imipramine. Pol J Pharmacol. 1995 Mar-Apr;47(2):127-36. PubMed PMID: 8688885.
7: Kodavanti UP, Lockard VG, Mehendale HM. In vivo toxicity and pulmonary effects of promazine and chlorpromazine in rats. J Biochem Toxicol. 1990 Winter;5(4):245-51. PubMed PMID: 1965728.
8: Hu OY, Tang HS, Sheeng TY, Chen SC, Lee SK, Chung PH. Pharmacokinetics of promazine: I. Disposition in patients with acute viral hepatitis B. Biopharm Drug Dispos. 1990 Oct;11(7):557-68. PubMed PMID: 2265236.
9: Merville MP, Piette J, Lopez M, Decuyper J, van de Vorst A. Termination sites of the in vitro DNA synthesis on single-stranded DNA photosensitized by promazines. J Biol Chem. 1984 Dec 25;259(24):15069-77. PubMed PMID: 6239864.
10: Hu OY, Tang HS, Sheeng TY, Chen TC, Curry SH. Pharmacokinetics of promazine in patients with hepatic cirrhosis–correlation with a novel galactose single point method. J Pharm Sci. 1995 Jan;84(1):111-4. PubMed PMID: 7714731.
11: Koytchev R, Alken RG, Kirkov V, Neshev G, Vagaday M, Kunter U. [Absolute bioavailability of chlorpromazine, promazine and promethazine]. Arzneimittelforschung. 1994 Feb;44(2):121-5. German. PubMed PMID: 8147942.
12: Hu OY, Curry SH. Stability, human blood distribution and rat tissue localization of promazine and desmonomethylpromazine. Biopharm Drug Dispos. 1989 Nov-Dec;10(6):537-48. PubMed PMID: 2611355.
13: Wang Q, Liu L, Yang X, Wang K, Chen N, Zhou C, Luo B, Du S. Evaluation of medicine effects on the interaction of myoglobin and its aptamer or antibody using atomic force microscopy. Anal Chem. 2015 Feb 17;87(4):2242-8. doi: 10.1021/ac503885e. Epub 2015 Feb 4. PubMed PMID: 25615803.
14: Sweatt JD, Palmer GC, Palmer SJ, Jackson TG, Manian AA. Benzo [b]-promazines, chlorpromazine free radical and analino-N, N-dimethylpropylamine analogs influence rat striatal DA-adenylate cyclase and calmodulin-phosphodiesterase. Arch Int Pharmacodyn Ther. 1982 Jun;257(2):188-99. PubMed PMID: 6287952.
15: Syrek M, Wójcikowski J, Daniel WA. Promazine pharmacokinetics during concurrent treatment with tricyclic antidepressants. Pol J Pharmacol. 1997 Nov-Dec;49(6):453-62. PubMed PMID: 9566049.
16: Wójcikowski J, Pichard-Garcia L, Maurel P, Daniel WA. Contribution of human cytochrome p-450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazine. Br J Pharmacol. 2003 Apr;138(8):1465-74. PubMed PMID: 12721102; PubMed Central PMCID: PMC1573803.
17: Daniel WA, Syrek M, Wójcikowski J. The influence of selective serotonin reuptake inhibitors on the plasma and brain pharmacokinetics of the simplest phenothiazine neuroleptic promazine in the rat. Eur Neuropsychopharmacol. 1999 Jun;9(4):337-44. PubMed PMID: 10422895.
18: John E. Promazine and neonatal hyperbilirubinaemia. Med J Aust. 1975 Aug 30;2(9):342-4. PubMed PMID: 1237776.
19: Ensafi AA, Hasanpour F, Khayamian T. Simultaneous chemiluminescence determination of promazine and fluphenazine using support vector regression. Talanta. 2009 Jul 15;79(2):534-8. doi: 10.1016/j.talanta.2009.04.023. Epub 2009 Apr 19. PubMed PMID: 19559917.
20: Ruokolainen M, Gul T, Permentier H, Sikanen T, Kostiainen R, Kotiaho T. Comparison of TiO2 photocatalysis, electrochemically assisted Fenton reaction and direct electrochemistry for simulation of phase I metabolism reactions of drugs. Eur J Pharm Sci. 2016 Feb 15;83:36-44. doi: 10.1016/j.ejps.2015.12.012. Epub 2015 Dec 10. PubMed PMID: 26690045.